Literature DB >> 9200557

Inhibitory effects of a fullerene derivative, dimalonic acid C60, on nitric oxide-induced relaxation of rabbit aorta.

M Satoh1, K Matsuo, H Kiriya, T Mashino, T Nagano, M Hirobe, I Takayanagi.   

Abstract

Dimalonic acid C60 (10(-5) M), a new fullerene derivative, produced an augmentation of phenylephrine-induced tone and reduced both the acetylcholine-induced maximum relaxation and the amplitude of substance P (10(-8) M)-induced relaxation in endothelium-containing thoracic aorta of rabbit; the acetylcholine- and substance P-induced relaxation was restored in the presence of superoxide dismutase (250 U/ml). Dimalonic acid C60 (10(-5) M) did not influence the phenylephrine-induced contractile response in the absence of endothelium, but the acetylcholine-induced relaxation was eliminated by removal of the endothelium. Superoxide anion generation, using hypoxanthine (1 mM)/xanthine oxidase (16 mU/ml), reduced the acetylcholine-induced relaxation and produced an augmentation of phenylephrine-induced tone in endothelium-containing strips; these effects were negated by the addition of superoxide dismutase (250 U/ml). A nitric oxide-generating agent, S-nitroso-N-acetylpenicillamine, caused relaxation of aorta without endothelium in a concentration-dependent manner, and the concentration-response curve was shifted to the right in the presence of dimalonic acid C60. This inhibitory effect of dimalonic acid C60 was also masked in the presence of superoxide dismutase. Sodium nitroprusside-induced relaxation was not affected by either dimalonic acid C60 or superoxide dismutase. These observations suggest that dimalonic acid C60 inhibits endothelium (nitric oxide)-dependent agonist-induced relaxation through the production of superoxide.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9200557     DOI: 10.1016/s0014-2999(97)89658-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers.

Authors:  D W Cagle; S J Kennel; S Mirzadeh; J M Alford; L J Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 2.  Medicinal applications of fullerenes.

Authors:  Rania Bakry; Rainer M Vallant; Muhammad Najam-ul-Haq; Matthias Rainer; Zoltan Szabo; Christian W Huck; Günther K Bonn
Journal:  Int J Nanomedicine       Date:  2007

3.  Modest vasomotor dysfunction induced by low doses of C60 fullerenes in apolipoprotein E knockout mice with different degree of atherosclerosis.

Authors:  Lise K Vesterdal; Janne K Folkmann; Nicklas R Jacobsen; Majid Sheykhzade; Håkan Wallin; Steffen Loft; Peter Møller
Journal:  Part Fibre Toxicol       Date:  2009-02-25       Impact factor: 9.400

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.